substance p and Complex Regional Pain Syndromes
substance p has been researched along with Complex Regional Pain Syndromes in 11 studies
Research
Studies (11)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bayer, M; Birklein, F; Engl, C; Escolano-Lozano, F; König, S; Rebhorn, C; Rittner, H | 1 |
| Choi, ES; Ham, HD; Lee, C; Lee, CH; Lee, S; Park, JH | 1 |
| Drummond, PD; Finch, PM; Goebel, A; Morellini, N | 1 |
| Clark, DJ; Guo, TZ; Kingery, WS; Li, WW; Shi, X; Sun, Y; Wei, T | 1 |
| Clark, JD; Guo, TZ; Kingery, WS; Li, WW; Wei, T | 1 |
| Clark, JD; Guo, TZ; Kingery, WS; Li, WW; Liang, D; Shi, X; Wei, T | 1 |
| Birklein, F; Schlereth, T | 1 |
| Clark, JD; Guo, TZ; Kingery, WS; Li, WW; Liang, DY; Sun, Y | 1 |
| Birklein, F; Isselmann, A; Leis, S; Schmelz, M; Weber, M | 1 |
| Finke, B; Gierer, P; Gradl, G; Mittlmeier, T; Schattner, S; Vollmar, B | 1 |
| Agashe, GS; Clark, JD; Davies, MF; Kingery, WS; Maze, M; Sawamura, S | 1 |
Trials
1 trial(s) available for substance p and Complex Regional Pain Syndromes
| Article | Year |
|---|---|
Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome.
Topics: Adult; Arm; Blood Proteins; Complex Regional Pain Syndromes; Female; Humans; Injections, Intradermal; Leg; Male; Microdialysis; Middle Aged; Neurogenic Inflammation; Reference Values; Regional Blood Flow; Skin; Substance P; Vasodilation | 2003 |
Other Studies
10 other study(ies) available for substance p and Complex Regional Pain Syndromes
| Article | Year |
|---|---|
Substance P Serum Degradation in Complex Regional Pain Syndrome - Another Piece of the Puzzle?
Topics: Bradykinin; Complex Regional Pain Syndromes; Humans; Peptide Hydrolases; Peptidyl-Dipeptidase A; Substance P | 2022 |
Analgesic effects of a 5-HT3 receptor antagonist in an animal model of complex regional pain syndrome.
Topics: Analgesics; Animals; Benzimidazoles; Brain Stem; Complex Regional Pain Syndromes; Cytokines; Disease Models, Animal; Pain; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Substance P; Tibial Fractures | 2021 |
Dermal nerve fibre and mast cell density, and proximity of mast cells to nerve fibres in the skin of patients with complex regional pain syndrome.
Topics: Adult; Cell Count; Complex Regional Pain Syndromes; Female; Humans; Male; Mast Cells; Middle Aged; Nerve Fibers; Pain Measurement; Skin; Skin Temperature; Substance P; Ubiquitin Thiolesterase | 2018 |
Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.
Topics: 2-Aminoadipic Acid; Animals; Anti-Inflammatory Agents; Complex Regional Pain Syndromes; Disease Models, Animal; Edema; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Minocycline; Neuroglia; Nociception; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord; Substance P; Tibial Fractures; Time Factors | 2015 |
Acute versus chronic phase mechanisms in a rat model of CRPS.
Topics: Animals; Antibodies; Antirheumatic Agents; Body Temperature; Complex Regional Pain Syndromes; Cytokines; Disease Models, Animal; Hindlimb; Indoles; Interleukin 1 Receptor Antagonist Protein; Male; Nerve Growth Factor; Neurokinin-1 Receptor Antagonists; Nociception; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Sciatic Nerve; Substance P; Tibial Fractures; Time Factors | 2016 |
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome.
Topics: Animals; Antirheumatic Agents; Caspase 1; Caspases, Initiator; Complex Regional Pain Syndromes; Cytokines; Enzyme-Linked Immunosorbent Assay; Fractures, Bone; Gene Expression Regulation; Indoles; Interleukin 1 Receptor Antagonist Protein; Keratinocytes; Keratins; Male; Nerve Growth Factor; Nerve Tissue Proteins; Pain Measurement; Pain Threshold; Physical Stimulation; Piperidines; Rats; Rats, Sprague-Dawley; Signal Transduction; Substance P; Time Factors | 2009 |
Mast cells: source of inflammation in complex regional pain syndrome?
Topics: Animals; Complex Regional Pain Syndromes; Disease Models, Animal; Male; Mast Cells; Nociception; Substance P; Tibial Fractures | 2012 |
Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.
Topics: Animals; Complex Regional Pain Syndromes; Disease Models, Animal; Indoles; Male; Mast Cells; Neurokinin-1 Receptor Antagonists; Nociception; Pain Measurement; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P; Tibial Fractures | 2012 |
Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain.
Topics: Animals; Chemotaxis, Leukocyte; Complex Regional Pain Syndromes; Disease Models, Animal; Edema; Endothelial Cells; Hyperalgesia; Hypesthesia; Infusion Pumps, Implantable; Injections, Intra-Arterial; Male; Microcirculation; Neurogenic Inflammation; Pain Measurement; Pain Threshold; Physical Stimulation; Rats; Rats, Sprague-Dawley; Substance P | 2007 |
Glucocorticoid inhibition of neuropathic hyperalgesia and spinal Fos expression.
Topics: Animals; Complex Regional Pain Syndromes; Hyperalgesia; Immunohistochemistry; Male; Methylprednisolone; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Spinal Cord; Substance P | 2001 |